Funding opp: Lung cancer impact award

Jim Siedow, PhD, Vice Provost for Research and Professor of Biology, and Sally Kornbluth, PhD, Vice Dean for Basic Science, Duke University School of Medicine announced the following new funding opportunity today. Note the internal Duke submission date is Thursday, Nov. 8, 2012. The National Lung Cancer Partnership and Uniting Against Lung Cancer announce a new funding opportunity intended to accelerate the movement of promising ideas in lung cancer research into clinical application. Our organizations are both dedicated to funding research aimed at improved treatments and a cure for lung cancer; we are partnering to offer a single award of $200,000 to rapidly bring new advances to the clinic and positively impact patient care. This award is intended to support clinical translational research that will promote significant improvements over current approaches in lung cancer prevention, detection or therapy. Applicants are expected to demonstrate an ability to produce significant progress for lung cancer patients in the near term. Applicants must present a strategic plan and timeline for clinical implementation within five years of the start of the two-year award period. The official announcement and description of this award may be found on the funding agency's website. [box]Duke internal deadline: Nov. 8, 2012.[/box] Requirements At the time of application, the Principal Investigator must hold position at or above the level of assistant professor at not-for-profit sponsoring institutions in the U.S. Eligibility Faculty, junior faculty. Award Amount The award provides funding of $200,000, including a maximum of $18,000 in indirect costs. Grants will be paid over two years at $100,000 per year. Grant funds may not be used for tuition, travel, or permanent equipment costs.